parthenolide has been researched along with Stomach Neoplasms in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Cao, Y; Li, Y; Liu, D; Liu, M; Yang, Y | 1 |
Li, Y; Xu, YH; Zhao, LJ | 1 |
2 other study(ies) available for parthenolide and Stomach Neoplasms
Article | Year |
---|---|
Parthenolide increases the sensitivity of gastric cancer cells to chemotherapy.
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Line, Tumor; Cell Proliferation; Cisplatin; Cyclin D1; Doxorubicin; Drug Resistance, Neoplasm; Drug Synergism; Humans; NF-kappa B; Proto-Oncogene Proteins c-bcl-2; Sesquiterpenes; Stomach Neoplasms | 2020 |
Effect of parthenolide on proliferation and apoptosis in gastric cancer cell line SGC7901.
Topics: Apoptosis; Cell Line, Tumor; Cell Proliferation; Cytochromes c; Humans; NF-kappa B; Sesquiterpenes; Stomach Neoplasms | 2009 |